Llwytho...
Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis
Background: Sarcoidosis goes into remission in two-thirds of patients with sarcoidosis, but about 20 % of patients develop pulmonary fibrosis. The mechanisms of pulmonary fibrosis in sarcoidosis and differences in pathogenesis between clinical stages are still unclear. Objectives: The aim of this st...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Sarcoidosis Vasc Diffuse Lung Dis |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Mattioli 1885
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170057/ https://ncbi.nlm.nih.gov/pubmed/32476874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v35i1.5834 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|